OR
BVS icon

Olympiad Research’s Bioventus BVS Stock Holding History

Olympiad Research’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,990
Closed -$73.5K – 120
2025
Q3 		$73.5K Buy
+10,990
New +$76.3K 0.1% 201
2025
Q2 		– Sell
-13,048
Closed -$119K – 196
2025
Q1 		$119K Sell
13,048
-649
-5% -$6.48K 0.14% 215
2024
Q4 		$144K Sell
13,697
-7,317
-35% -$86.5K 0.15% 211
2024
Q3 		$251K Buy
+21,014
New +$182K 0.16% 225

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Olympiad Research's BVS Position: Q4 2025 in Review

Olympiad Research sold out of Bioventus (BVS) in Q4 2025, closing a stake of 10,990 shares — an estimated $73.5K sold.

Olympiad Research first reported a position in BVS in Q3 2024 and held it in 4 quarters. The position peaked at $251K in Q3 2024. 148 funds tracked by Wall St. Rank hold BVS as of Q4 2025.

  • Olympiad Research reported no remaining Bioventus position as of Q4 2025 after selling out during the quarter.
  • Olympiad Research sold 10,990 Bioventus shares in Q4 2025, an estimated $73.5K.
  • Olympiad Research first reported a position in Bioventus in Q3 2024 and held it in 4 quarters.
  • Olympiad Research's Bioventus position peaked at $251K in Q3 2024.
  • 148 funds tracked by Wall St. Rank held Bioventus as of Q4 2025.

Based on Olympiad Research's 13F filing for Q4 2025, filed 17 Feb 2026.